Skip to content

Sentinel Surveillance of Malnutrition, Niger

Sentinel Surveillance of Acute Malnutrition in the Region of Maradi, Niger, Children Under 5: Impact of a Preventive Intervention

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00682708
Enrollment
Unknown
Registered
2008-05-22
Start date
2006-08-31
Completion date
2008-03-31
Last updated
2008-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malnutrition

Keywords

malnutrition, ready to use food, Niger

Brief summary

Malnutrition is a critical public health problem in developing countries. Malnutrition may be linked to more than one half of the deaths in children under 5 years old. In July 2001, after an intervention related to a measles epidemic, Medecins sans Frontieres-France opened a nutritional program in Maradi, in the South of Niger. The introduction of ready to use therapeutic foods (RUTF), in particular Plumpy'Nut (Nutriset, France) allowed for the treatment of the majority of children at their homes using ambulatory treatment. Children with complicated cases were cared for in an inpatient center. With ambulatory treatment the number of children cared for in the MSF program reached close to 70000 in 2006. This study aimed to assess the effect of a 3-month distribution of RUTF in the context of a preventative supplementary feeding program. The primary hypotheses were that short-term RUTF supplementation at the village-level would prevent declines in weight-for-height and reduce the incidence of wasting in children 6 to 60 mo of age over a period of 8 mo. Because RUTF may have additional health effects, the intervention effect on height-for-age, stunting, mortality and morbidity from malaria, diarrhea, and respiratory infection were also examined.

Interventions

DIETARY_SUPPLEMENTPlumpyNut
DIETARY_SUPPLEMENTPlumpyDoz

Sponsors

Ministry of Health, Niger
CollaboratorUNKNOWN
Medecins Sans Frontieres, Netherlands
CollaboratorOTHER
Epicentre
Lead SponsorOTHER

Study design

Primary purpose
PREVENTION

Eligibility

Sex/Gender
ALL
Age
6 Months to 59 Months
Healthy volunteers
Yes

Inclusion criteria

* All children resident in randomized villages 6-59 months

Exclusion criteria

* N/A

Design outcomes

Primary

MeasureTime frame
weight-for-height in children 6 to 60 mo of age8 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 4, 2026